Gallid herpesvirus 3 (ATCC® VR-2002)

Classification: Herpesviridae, Mardivirus  /  Product Format: frozen

Classification Herpesviridae, Mardivirus
Deposited As Marek's disease virus type 2
Agent Gallid herpesvirus 3
Strain SB
Applications
NOTE: This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims.
Will protect against MDV and non-virus producing JM tumor transplant.
Biosafety Level 2
Isolation
chicken (S-strain) peripheral blood lymphocytes
Product Format frozen
Storage Conditions  Vapor phase of liquid nitrogen
Comments
Nononcogenic, cell associated. Will protect against MDV and non-virus producing JM tumor transplant. NOTE: This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims.
Effect on Host
 CPE, cell rounding and syncytia formation
Recommended Host
chicken embryo fibroblasts
Growth Conditions
Temperature: 37°C
Incubation:  Incubate infected culture for 7 days at 37°C in a humidified 5% CO2 atmosphere, until CPE are well advance throughout.

Effect on Host
 CPE, cell rounding and syncytia formation
Name of Depositor BW Calnek
Source
chicken (S-strain) peripheral blood lymphocytes
References

Schat KA, Calnek BW. Characterization of an apparently nononcogenic Marek's disease. J. Natl. Cancer Inst. 60: 1075-1082, 1978. PubMed: 76680